The use of high flow oxygen therapy (Optiflow®) is increasing, but clear indications are lacking. This pragmatic review describes the current evidence for the use of high flow oxygen therapy in the intensive care unit in three different patient populations: Acute hypoxaemic respiratory failure, (prevention of) post-extubation failure and during interventions.
|Number of pages||4|
|Journal||Netherlands Journal of Critical Care|
|Publication status||Published - 1 Nov 2019|